EQUASENS financials
EQUASENS
96950066I7XVFGZI8L92 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €216.8M | €219.8M |
| Employee benefits expense | €87.1M | €80.8M |
| Raw materials & consumables used | €40.3M | €41.5M |
| Depreciation & amortisation | €14.8M | €13.2M |
| Operating profit (EBIT) | €43.7M | €55.2M |
| Income tax expense | €9.5M | €9.7M |
| Profit for the year | €37.8M | €48.9M |
| — attributable to owners | €36.2M | €47.0M |
| — attributable to NCI | €1.5M | €1.8M |
| Total comprehensive income | €37.4M | €48.4M |
| Per share | ||
| Basic EPS | €2.41 | €3.13 |
| Diluted EPS | €2.39 | €3.10 |
| Free cash flow / share | €2.27 | €2.73 |
| Cash flow statement | ||
| Net cash from operating activities | €47.6M | €57.7M |
| Net cash from investing activities | -€13.9M | -€42.9M |
| Net cash from financing activities | -€36.2M | -€19.9M |
| Dividends paid | €19.3M | €17.9M |
| Proceeds from borrowings | €9.0M | €18.2M |
| Repayments of borrowings | €24.0M | €20.2M |
| Balance sheet | ||
| Total assets | €398.0M | €394.0M |
| Non-current assets | €275.6M | €261.8M |
| Intangible assets & goodwill | €104.0M | €90.2M |
| Current assets | €122.5M | €132.3M |
| Inventories | €10.3M | €10.3M |
| Trade & other receivables | €47.4M | €52.8M |
| Cash & equivalents | €16.0M | €18.4M |
| Total equity | €240.7M | €227.6M |
| — attributable to owners | €231.5M | €219.3M |
| Non-controlling interests | €9.2M | €8.3M |
| Non-current liabilities | €55.8M | €58.3M |
| Current liabilities | €101.6M | €108.1M |
| Deferred tax liabilities | €1.7M | €1.6M |
| Derived metrics | ||
| Free cash flow | €35.9M | €43.1M |
| Operating margin | 20.2% | 25.1% |
| Net margin | 17.4% | 22.2% |
| Return on equity | 15.7% | 21.5% |
| Cash conversion ratio | 1.26× | 1.18× |
| Capex coverage | 4.08× | 3.94× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -€13.0K | -€916.0K |
| Adjustments For Decrease Increase In Trade Account Receivable | €4.6M | -€6.0M |
| Adjustments For Increase Decrease In Trade Account Payable | -€2.5M | -€1.2M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | €226.0K | €44.0K |
| Adjustments For Sharebased Payments | €325.0K | €352.0K |
| Bank Overdrafts Classified As Cash Equivalents | €0 | €0 |
| Basic Earnings Loss Per Share From Continuing Operations | €2.41 | €3.13 |
| Cash Flows From Used In Operations Before Changes In Working Capital | €46.9M | €61.6M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €14.9M | €8.3M |
| Comprehensive Income Attributable To Noncontrolling Interests | €1.5M | €1.8M |
| Comprehensive Income Attributable To Owners of Parent | €35.9M | €46.6M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | €18.6M | €19.1M |
| Current Provisions | €304.0K | €603.0K |
| Current Tax Liabilities | €493.0K | €1.4M |
| Deferred Tax Assets | €3.5M | €3.5M |
| Diluted Earnings Loss Per Share From Continuing Operations | €2.39 | €3.10 |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | €18.8M | €17.3M |
| Dividends Paid To Noncontrolling Interests | €554.0K | €589.0K |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners | €18.8M | — |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | €1.25 | — |
| Dividends Recognised As Distributions To Owners Per Share | €1.25 | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €100.0K | €25.0K |
| Equity and Liabilities | €398.0M | €394.0M |
| Impairment Loss Recognised In Profit Or Loss Trade Receivables | €674.0K | €172.0K |
| Income Tax Relating To Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | -€124.0K | -€175.0K |
| Income Taxes Paid Refund Classified As Operating Activities | €10.9M | €6.9M |
| Increase Decrease In Cash and Cash Equivalents | -€2.4M | -€5.0M |
| Increase Decrease In Working Capital | -€619.0K | €3.9M |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | -€1.4M | -€76.0K |
| Increase Decrease Through Exercise of Options | -€4.0M | €0 |
| Increase Decrease Through Sharebased Payment Transactions | €325.0K | €352.0K |
| Increase Decrease Through Transactions With Owners | -€24.4M | -€17.6M |
| Increase Decrease Through Treasury Share Transactions | €67.0K | €12.0K |
| Intangible Assets Other Than Goodwill | €46.0M | €40.1M |
| Interest Expense | €1.1M | €669.0K |
| Interest Income On Cash and Cash Equivalents | €5.0M | €3.9M |
| Interest Paid Classified As Operating Activities | €1.1M | €669.0K |
| Interest Received Classified As Investing Activities | €5.0M | €3.9M |
| Investment Accounted For Using Equity Method | €8.6M | €9.0M |
| Issued Capital | €3.0M | €3.0M |
| Noncurrent Financial Assets | €80.6M | €83.1M |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | €3.0M | €3.0M |
| Noncurrent Portion of Other Noncurrent Borrowings | €29.9M | €39.3M |
| Noncurrent Provisions For Employee Benefits | €8.2M | €7.1M |
| Other Comprehensive Income | -€351.0K | -€464.0K |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€496.0K | -€699.0K |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | €86.0K | €60.0K |
| Other Current Financial Assets | €31.4M | €36.3M |
| Other Finance Cost | €547.0K | €999.0K |
| Other Finance Income | €0 | €0 |
| Other Inflows Outflows of Cash Classified As Investing Activities | -€65.0K | -€45.0K |
| Payments From Changes In Ownership Interests In Subsidiaries | €1.9M | €0 |
| Payments To Acquire Or Redeem Entitys Shares | €6.1M | €5.2M |
| Proceeds From Disposals of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | €389.0K | €33.0K |
| Proceeds From Sale Or Issue of Treasury Shares | €6.2M | €5.2M |
| Proceeds From Sales Or Maturity of Financial Instruments Classified As Investing Activities | €39.4M | €34.7M |
| Profit Loss From Continuing Operations | €37.8M | €48.9M |
| Profit Loss From Discontinued Operations | €0 | €0 |
| Purchase of Financial Instruments Classified As Investing Activities | €32.1M | €58.5M |
| Purchase of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | €11.6M | €14.7M |
| Retained Earnings Profit Loss For Reporting Period | €36.2M | €47.0M |
| Services Expense | €27.4M | €27.6M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €197.0K | €1.2M |
| Tax Expense Other Than Income Tax Expense | €3.0M | €2.9M |
| Trade and Other Current Payables To Trade Suppliers | €13.9M | €16.1M |
| Treasury Shares | €9.9M | €10.0M |
Every line item above is a fact tagged in EQUASENS's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.